-
Targacept (TRGT) Files To Offer 2.2M Shares
Thursday, October 8, 2009 - 9:17am | 37This morning Targacept (Nasdaq: TRGT) filed to sell 2.2 million shares of stock. Targacept is in the biopharmaceutical business. Deutsche Bank (NYSE: DB) is underwriting the Targacept offering.
-
UBS Upgrades PPG Industries (PPG) to Neutral from Sell
Wednesday, September 16, 2009 - 6:20am | 40PPG Industries (NYSE: PPG) and Olin Corp (NYSE: OLN) were upgraded by UBS (NYSE: UBS) to Neural following price increases for chlorine and caustic soda.
-
Biggest Losers (ZOOM,KR,TIV,HNT)
Tuesday, September 15, 2009 - 11:31am | 282Zoom Technologies, Inc. (NASDAQ: ZOOM) - After yesterday’s massive rally of 212%, the stock has corrected about 15%to $10.81 largely on profit booking. A total of 958K shares being traded till now. Yesterday, it announced the results of its recently approved acquisition, Gold Lion. The newly...
-
New 52-Week High Stocks –SLXP,TA,ZOOM,CHTP,MOT
Monday, September 14, 2009 - 11:41am | 247Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP) crossed earlier 52-week high of $13.99 and touched a new 52-week high at $21.34 in today’s morning trade. Currently the stock is trading at $20.12, up 50.37% on 9.18 million shares – over 28X than the total daily average volume. At $20.12, the stock is...
-
NYSE Euronext (NYX) to Sell Stakes in AMEX Unit (BAC, BARC, UBS, C, AMTD, GS, NYX)
Wednesday, September 9, 2009 - 10:04am | 207Based on the agreement likely to be announced on Wednesday, the New York Stock Exchange parent company's stake in AMEX will be reduced to less than 50%. However, NYSE will remain as the largest shareholder with an eye on strengthening its U.S. options-trading business. NYSE Euronext (NYSE: NYX)...
-
UBS Raises Human Genome Price Target to $25 Based on Acquisition Potential
Friday, September 4, 2009 - 8:36am | 52Human Genome's price target was raised at UBS to $25 from $18 taking into account its acquisition potential. UBS believes that Glaxosmithkline (GSK) is the obvious acquirer didn’t dare to predict it. The firm rates shares a Buy.
-
Markets In Everything: Early Boarding for $10
Thursday, September 3, 2009 - 2:53pm | 50CS Monitor -- Fans of Southwest Airlines’s folksy and egalitarian ways are in for a culture shock: From now on, customers who pay an extra $10 will get a head start on boarding.
-
Credit Suisse (CS) Downgrades Hovnanian (HOV)
Thursday, September 3, 2009 - 8:48am | 45Credit Suisse (NYSE: CS) downgraded Hovnanian (HOV) to Underperform from Neutral. Credit Suisse cites eroding equity value from Hovnanian’s write-downs and operating losses for the downgrade. Hovnanian has a price target of $2 on shares.
-
Gold (GLD) Breaking Out of a Narrow Triangle on Charts, Silver (SLV) Continues Strong
Wednesday, September 2, 2009 - 3:14pm | 359Gold breaking out is either the reflation trade version 48.148 OR "uh oh something bad is coming down the pike" trade ... gold has been in a big descending triangle getting narrower and narrower; when those break out in either direction it is generally a big move. May - June 2009: $900 - $1000July...
-
Blackstone Group (BX) Becomes Top "Fund of Fund" Player
Thursday, August 27, 2009 - 2:51pm | 452This came out of left field... somehow Blackstone Group (BX) has become the #1 player in fund of (hedge) funds. I guess not getting caught up with Bernie Madoff has its priveledges. Via NY Post Considering this is not their core business, it is just icing on the cake. But really why am I...
-
International Paper Target Raised to $28 from $24 at Deutsche Bank (DB)
Thursday, August 27, 2009 - 8:23am | 40Deutsche Bank (NYSE: DB) raised its target on International Paper on valuation. It believes that the company's industry continues to gradually improve and provide upside surprises. Deutsche Bank maintains a Buy rating on the stock.
-
Former Head of Merrill Lynch (MER) Negotiates With Bofa (BAC)
Thursday, August 27, 2009 - 6:23am | 81Robert McCann, former head of Merrill Lynch's (NYSE: AMO) wealth management unit, is in talks to settle a suit he filed August 24 against Bank of America Corp (NYSE: BAC) seeking to lift a non-compete clause, allowing him to join a chief rival. McCann, a three-decade Merrill Lynch veteran, has...
-
Genzyme Allston update at Deutsche Bank (DB)
Tuesday, August 25, 2009 - 9:53am | 46Deutsche Bank (NYSE: DB) said the FDA cleared 2 remaining lots of finished Cerezyme product for use. The EMEA is evaluating if they will release these lots. The firm believes this is a positive for Genzyme's revenue guidance. Shares are Buy rated.
-
Activision (ATVI) new games will boost company, says Deutsche Bank (DB)
Tuesday, August 25, 2009 - 9:36am | 43After Activision Blizzard (NASDAQ: ATVI) announced a number of new games, Deutsche Bank (NYSE: DB) is more positive on the company's prospects for 2010 and 2011. The firm maintains a Buy rating on the stock.
-
New Big Mac Index: Working Time To Buy Big Mac
Monday, August 24, 2009 - 2:44pm | 145THE ECONOMIST -- The size of your pay packet may be important, but so is its purchasing power. Helpfully, a UBS report published this week offers a handy guide to how long it takes a worker on the average net wage to earn the price of a Big Mac in 73 cities. Fast-food junkies are best off in...